Literature DB >> 22679317

Vanishing bile duct syndrome in a HIV patient on HAART therapy.

Jerome Gnanaraj1, Paul Fiedler, Michael Virata.   

Abstract

Vanishing bile duct syndrome refers to a group of disorders characterised by progressive destruction of the intrahepatic bile ducts resulting in cholestasis. It is a final common pathway for many disorders. The diagnoses is mainly made by histological findings. To consider a diagnosis there should be loss of interlobular bile ducts in more than fifty per cent of small portal tracts provided that the specimen contains at least 10 portal tracts. Here the authors present a case of vanishing bile duct syndrome which developed after initiation of highly active antiretroviral treatment therapy.

Entities:  

Mesh:

Year:  2011        PMID: 22679317      PMCID: PMC3185399          DOI: 10.1136/bcr.06.2011.4369

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Small bile duct abnormalities in sarcoidosis.

Authors:  J R Murphy; M H Sjogren; J W Kikendall; D A Peura; Z Goodman
Journal:  J Clin Gastroenterol       Date:  1990-10       Impact factor: 3.062

Review 2.  Small-duct primary sclerosing cholangitis.

Authors:  J Ludwig
Journal:  Semin Liver Dis       Date:  1991-02       Impact factor: 6.115

Review 3.  New pathogenetic insights into the sarcoid granuloma.

Authors:  C Agostini; F Adami; G Semenzato
Journal:  Curr Opin Rheumatol       Date:  2000-01       Impact factor: 5.006

Review 4.  Disappearing intrahepatic bile ducts: the syndromes and their mechanisms.

Authors:  G M Woolf; J M Vierling
Journal:  Semin Liver Dis       Date:  1993-08       Impact factor: 6.115

Review 5.  Pathology and pathogenesis of intrahepatic bile duct loss.

Authors:  Y Nakanuma; K Tsuneyama; K Harada
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

6.  Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis.

Authors:  J Ludwig; R H Wiesner; N F LaRusso
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

7.  Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury.

Authors:  Suthat Liangpunsakul; Paul Kwo; George K Koukoulis
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 2.566

8.  A case of vanishing bile duct syndrome and IBD secondary to Hodgkin's lymphoma.

Authors:  Anthony T DeBenedet; Carl L Berg; Kyle B Enfield; Randall L Woodford; Audrey K Bennett; Patrick G Northup
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-01

9.  Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

Authors:  A Wee; J Ludwig
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

10.  Antimitochondrial antibody-negative primary biliary cirrhosis.

Authors:  M A Lacerda; J Ludwig; E R Dickson; R A Jorgensen; K D Lindor
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

  10 in total
  1 in total

1.  Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.

Authors:  Matthew Mason; Oyedele Adeyi; Scott Fung; Barbara-Ann Millar
Journal:  BMJ Case Rep       Date:  2014-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.